Anthem, Inc. (ANTM) Stock Rating Upgraded by Zacks Investment Research
Anthem, Inc. (NYSE:ANTM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday. The firm presently has a $207.00 target price on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 12.81% from the company’s previous close.
According to Zacks, “Anthem’s shares have outperformed the industry in last one year. The company’s diverse product portfolio has helped in improving underwriting results. Anthem’s strategic acquisitions, divestitures and ACO arrangements further pave the way for long-term growth. Its rising level of medical membership continues to boost the top line. Its strong capital position backs effective capital deployment. Its frequent share buyback programs and regular dividend payments primarily aim at enhancing shareholders’ value. The company has seen the Zacks Consensus Estimate for 2017 and 2018 earnings being revised upward over the last 60 days. Followed by strong results in first half of 2017, the company has raised the earnings and revenue guidance for 2017.”
Other research analysts have also issued reports about the stock. Jefferies Group LLC restated a “hold” rating and set a $204.00 target price on shares of Anthem in a research report on Friday, July 14th. Deutsche Bank AG increased their price target on shares of Anthem from $173.00 to $185.00 and gave the company a “hold” rating in a research report on Thursday, July 13th. BidaskClub upgraded shares of Anthem from a “hold” rating to a “buy” rating in a research report on Wednesday, September 6th. Cantor Fitzgerald reiterated a “buy” rating and issued a $215.00 price target on shares of Anthem in a research report on Thursday, September 14th. Finally, Bank of America Corporation increased their price target on shares of Anthem from $224.00 to $228.00 and gave the company a “buy” rating in a research report on Friday, July 14th. Ten analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $181.95.
Anthem (NYSE:ANTM) opened at 183.50 on Wednesday. Anthem has a 52 week low of $114.85 and a 52 week high of $198.98. The stock has a market capitalization of $48.18 billion, a price-to-earnings ratio of 17.35 and a beta of 0.70. The company has a 50-day moving average of $191.59 and a 200-day moving average of $182.25.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, topping the consensus estimate of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The company had revenue of $22.20 billion for the quarter, compared to analyst estimates of $22.25 billion. During the same period in the prior year, the business posted $3.33 earnings per share. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. Analysts anticipate that Anthem will post $11.83 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Anthem, Inc. (ANTM) Stock Rating Upgraded by Zacks Investment Research” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/22/anthem-inc-antm-stock-rating-upgraded-by-zacks-investment-research.html.
In other Anthem news, EVP Thomas C. Zielinski sold 9,127 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $191.25, for a total transaction of $1,745,538.75. Following the transaction, the executive vice president now owns 26,571 shares of the company’s stock, valued at $5,081,703.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Joseph Swedish sold 21,125 shares of the stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $197.00, for a total transaction of $4,161,625.00. Following the transaction, the insider now directly owns 87,668 shares in the company, valued at approximately $17,270,596. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 30,776 shares of company stock worth $6,007,143. 0.36% of the stock is currently owned by insiders.
Large investors have recently bought and sold shares of the business. Captrust Financial Advisors purchased a new position in Anthem during the second quarter worth approximately $128,000. Westside Investment Management Inc. raised its stake in Anthem by 33.6% during the first quarter. Westside Investment Management Inc. now owns 795 shares of the company’s stock worth $131,000 after purchasing an additional 200 shares during the period. Salem Investment Counselors Inc. raised its stake in Anthem by 1.4% during the second quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock worth $134,000 after purchasing an additional 10 shares during the period. Focused Wealth Management Inc purchased a new position in Anthem during the first quarter worth approximately $149,000. Finally, Harding Loevner LP purchased a new position in Anthem during the second quarter worth approximately $151,000. 87.65% of the stock is currently owned by institutional investors.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.